Detalhe da pesquisa
1.
AGI-134: a fully synthetic α-Gal glycolipid that converts tumors into in situ autologous vaccines, induces anti-tumor immunity and is synergistic with an anti-PD-1 antibody in mouse melanoma models.
Cancer Cell Int
; 19: 346, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31889898
2.
Small molecules targeting hepatitis C virus-encoded NS5A cause subcellular redistribution of their target: insights into compound modes of action.
J Virol
; 85(13): 6353-68, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21507963